Entering text into the input field will update the search result below

Charles River Laboratories rises 8% on Q3 earnings beat

Quarterly results

CharlieAJA

  • Charles River Laboratories (NYSE:CRL) is trading 8.4% higher the company posted better-than expected Q3 result and raised the lower end of its profit guidance, helped by strong performance in its Discovery and Safety Assessment unit.
  • The company now expects 2022 profit of $10.80-$10.95

Recommended For You

About CRL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CRL--
Charles River Laboratories International, Inc.